Latest Information Update: 10 Oct 2002
At a glance
- Originator Solvay
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 16 Sep 2002 Discontinued - Phase-II for Gastrointestinal disorders in USA (unspecified route)
- 30 Aug 2000 Phase-II clinical trials in Gastrointestinal disorders in USA (unspecified route)
- 30 Aug 2000 New profile